These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7003391)

  • 1. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
    Kane JP; Malloy MJ; Tun P; Phillips NR; Freedman DD; Williams ML; Rowe JS; Havel RJ
    N Engl J Med; 1981 Jan; 304(5):251-8. PubMed ID: 7003391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia.
    Illingworth DR; Phillipson BE; Rapp JH; Connor WE
    Lancet; 1981 Feb; 1(8215):296-8. PubMed ID: 6109940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B.
    Vega GL; East C; Grundy SM
    Arteriosclerosis; 1989; 9(1 Suppl):I135-44. PubMed ID: 2912427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
    Glueck CJ; Fallat RW; Mellies M; Tsang RC
    Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia.
    Malloy MJ; Kane JP; Kunitake ST; Tun P
    Ann Intern Med; 1987 Nov; 107(5):616-23. PubMed ID: 3662275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR; Bacon S
    Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ; Linden CV; O'Connell MJ; Heilman J
    Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
    Witztum JL; Schonfeld G; Weidman SW
    J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
    Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
    N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
    Brown G; Albers JJ; Fisher LD; Schaefer SM; Lin JT; Kaplan C; Zhao XQ; Bisson BD; Fitzpatrick VF; Dodge HT
    N Engl J Med; 1990 Nov; 323(19):1289-98. PubMed ID: 2215615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probucol with colestipol in the treatment of hypercholesterolemia.
    Dujovne CA; Krehbiel P; Decoursey S; Jackson B; Chernoff SB; Pitterman A; Garty M
    Ann Intern Med; 1984 Apr; 100(4):477-82. PubMed ID: 6367578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
    Goodman DS; Noble RP; Dell RB
    J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
    Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
    Illingworth DR
    Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
    Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
    Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined drug therapy for familial hypercholesterolemia.
    Packard CJ; Stewart JM; Morgan HG; Lorimer AR; Shepherd J
    Artery; 1980; 7(4):281-9. PubMed ID: 7213018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB; Bell C; Olson L
    Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose colestipol plus probucol for hypercholesterolemia.
    Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H
    Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
    Sundberg EE; Illingworth DR
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7631-5. PubMed ID: 6584876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.